Microparticles (MPs) are known to increase in various malignancies and are involved in tumor invasion, angiogenesis, coagulation, and metastasis. We investigated the plasma levels of Annexin-V MPs, (AV + MPs), platelet-derived MPs (PMPs) and endothelial-derived MPs (EMPs) in patients with melanoma (n = 129) and in healthy controls (n = 49). A functional coagulation test STA Procoag-PPL ® measuring the clotting time was performed on samples containing MPs to evaluate their procoagulant potential. The plasma levels of PMPs, EMPs and AV + MPs were significantly higher and the clotting time-PPL was significantly lower in melanoma patients than in healthy controls. The plasma levels of PMPs, EMPs and AV + MPs were higher in stage IV than in the other stages of melanoma but with no significant difference. In addition, we observed an inverse correlation between PMPs, AV + MPs, and clotting times. Our data suggest that MPs are involved in the progression of melanoma and may be associated to melanoma-associated thrombogenesis. 

